Recombinant iss as a potential vaccine for avian colibacillosis

Avian Diseases

Volumn 56, Issue 1, 2012, Pages 192-199

  Lynne, Aaron M ^a,b   Kariyawasam, Subhashinie ^a,c   Wannemuehler, Yvonne ^a   Johnson, Timothy J ^a,d   Johnson, Sara J ^a   Sinha, Avanti S ^a   Lynne, Dorie K ^a   Moon, Harley W ^a   Jordan, Dianna M ^e   Logue, Catherine M ^a   Foley, Steven L ^f   Nolan, Lisa K ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Sam Houston State University   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

^f MARSHFIELD CLINIC   (United States)

Author keywords

APEC; colibacillosis; ExPEC; immunization; Iss; vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI VACCINE; ISS PROTEIN, E COLI; RECOMBINANT PROTEIN;

AIR SAC; ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BIRD DISEASE; CHICKEN; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GERMFREE ANIMAL; IMMUNOLOGY; MICROBIOLOGY; MUCOSA;

AIR SACS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; MUCOUS MEMBRANE; POULTRY DISEASES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

AVES; ESCHERICHIA COLI; GALLUS GALLUS;

EID: 84859333240     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9861-072111-Reg.1     Document Type: Article

References (48)

1. Amoako, K. K., T. Prysliak, A. A. Potter, S. K. Collinson, W. W. Kay, and B. J. Allan. Attenuation of an avian pathogenic Escherichia coli strain due to a mutation in the rpsL gene. Avian Dis. 48:19-25. 2004.
2. Arp, L. H. Effect of passive immunization on phagocytosis of blood-borne Escherichia coli in spleen and liver of turkeys. Am. J. Vet. Res. 43:1034-1040. 1982.
3. Barnes, H. J., L. K. Nolan, and J. P. Vaillancourt. Colibacillosis. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Blackwell Publishing, Ames, IA. pp. 691-732. 2008.
4. Barondess, J. J., and J. Beckwith. Bor gene of phage lambda, involved in serum resistance, encodes a widely conserved outer membrane lipoprotein. J. Bacteriol. 177:1247-1253. 1995.
5. Binns, M. M., D. L. Davies, and K. G. Hardy. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature 279:778-781. 1979.
6. Bolin, C. A., and A. E. Jensen. Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from Escherichia coli septicemia. Infect. Immun. 55:1239-1242. 1987.
7. Chaffer, M., B. Schwartsburd, and E. D. Heller. Vaccination of turkey poults against pathogenic Escherichia coli. Avian Pathol. 26:377-390. 1997.
8. Chuba, P. J., M. A. Leon, A. Banerjee, and S. Palchaudhuri. Cloning and DNA sequence of plasmid determinant iss, coding for increased serum survival and surface exclusion, which has homology with lambda DNA. Mol. Gen. Genet. 216:287-292. 1989.
9. Chuba, P. J., S. Palchaudhuri, and M. A. Leon. Contributions of traT and iss genes to the serum resistance phenotype of plasmid ColV2-K94. FEMS Microbiol. Lett. 37:135-138. 1986.
10. Crawford, L. Animal drugs, feeds, and related products; enrofloxacin for poultry; withdrawal of approval of new animal drug application. Docket No. 2000N-1571, OC 2005194. Final Rule. pp. 44048-44049. 2005.
11. Deb, J. R., and E. G. Harry. Laboratory trials with inactivated vaccines against Escherichia coli (O78 K80) infection in fowls. Res. Vet. Sci. 20:131-138. 1976.
12. Deb, J. R., and E. G. Harry. Laboratory trials with inactivated vaccines against Escherichia coli (O2:K1) infection in fowls. Res. Vet. Sci. 24:308-313. 1978.
13. Foley, S. L., S. M. Horne, C. W. Giddings, M. Robinson, and L. K. Nolan. Iss from a virulent avian Escherichia coli. Avian Dis. 44:185-191. 2000.
14. Frommer, A., P. J. Freidlin, R. R. Bock, G. Leitner, M. Chaffer, and E. D. Heller. Experimental vaccination of young chickens with a live, non-pathogenic strain of Escherichia coli. Avian Pathol. 23:425-433. 1994.
15. Gyimah, J. E., B. Panigrahy, and J. D. Williams. Immunogenicity of an Escherichia coli multivalent pilus vaccine in chickens. Avian Dis. 30:687-689. 1986.
16. Horne, S. M., S. J. Pfaff-McDonough, C. W. Giddings, and L. K. Nolan. Cloning and sequencing of the iss gene from a virulent avian Escherichia coli. Avian Dis. 44:179-184. 2000.
17. Ike, K., K. Kawahara, H. Danbara, and K. Kume. Serum resistance and aerobactin iron uptake in avian Escherichia coli mediated by conjugative 100-megadalton plasmid. J. Vet. Med. Sci. 54:1091-1098. 1992.
18. Johnson, J. R., P. Delavari, A. L. Stell, T. S. Whittam, U. Carlino, and T. A. Russo. Molecular comparison of extraintestinal Escherichia coli isolates of the same electrophoretic lineages from humans and domestic animals. J. Infect. Dis. 183:154-159. 2001.
19. Johnson, T. J., S. J. Johnson, and L. K. Nolan. Complete DNA sequence of a ColBM plasmid from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV virulence plasmids. J. Bacteriol. 188:5975-5983. 2006.
20. Johnson, T. J., S. Kariyawasam, Y. Wannemuehler, P. Mangiamele, S. J. Johnson, C. Doetkott, J. A. Skyberg, A. M. Lynne, J. R. Johnson, and L. K. Nolan. The genome sequence of avian pathogenic Escherichia coli strain o1:k1:h7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J. Bacteriol. 189:3228-3236. 2007.
21. Johnson, T. J., C. M. Logue, Y. Wannemuehler, S. Kariyawasam, C. Doetkott, C. DebRoy, D. G. White, and L. K. Nolan. Examination of the source and extended virulence genotypes of Escherichia coli contaminating retail poultry meat. Foodborne Pathog. Dis. 6:657-667. 2009.
22. Johnson, T. J., K. E. Siek, S. J. Johnson, and L. K. Nolan. DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains. J. Bacteriol. 188: 745-758. 2006.
23. Johnson, T. J., Y. Wannemuehler, C. Doetkott, S. J. Johnson, S. C. Rosenberger, and L. K. Nolan. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J. Clin. Microbiol. 46:3987-3996. 2008.
24. Johnson, T. J., Y. Wannemuehler, S. J. Johnson, A. L. Stell, C. Doetkott, J. R. Johnson, K. S. Kim, L. Spanjaard, and L. K. Nolan. Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl. Environ. Microbiol. 74:7043-7050. 2008.
25. Kariyawasam, S., B. N. Wilkie, and C. L. Gyles. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli. Avian Dis. 48:287-299. 2004.
26. Kariyawasam, S., B. N. Wilkie, and C. L. Gyles. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies. Vet. Microbiol. 98:273-284. 2004.
27. Kariyawasam, S., B. N. Wilkie, D. B. Hunter, and C. L. Gyles. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis. 46:668-678. 2002.
28. Kuby, J. Immunology, 3rd ed. W. H. Freeman and Company, New York. 1998.
29. Kwaga, J. K., B. J. Allan, J. V. van der Hurk, H. Seida, and A. A. Potter. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infect. Immun. 62:3766-3772. 1994.
30. Lynne, A. M., S. L. Foley, and L. K. Nolan. Immune response to recombinant Escherichia coli Iss protein in poultry. Avian Dis. 50:273-276. 2006.
31. Lynne, A. M., J. A. Skyberg, C. M. Logue, and L. K. Nolan. Detection of Iss and Bor on the surface of Escherichia coli. J. Appl. Microbiol. 102:660-666. 2007.
32. Melamed, D., G. Leitner, and E. D. Heller. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli. Avian Dis. 35:17-22. 1991.
33. Moulin-Schouleur, M., C. Schouler, P. Tailliez, M. R. Kao, A. Bree, P. Germon, E. Oswald, J. Mainil, M. Blanco, and J. Blanco. Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. J. Clin. Microbiol. 44:3484-3492. 2006.
34. Nolan, L. K., S. M. Horne, C. W. Giddings, S. L. Foley, T. J. Johnson, A. M. Lynne, and J. Skyberg. Resistance to serum complement, iss, and virulence of avian Escherichia coli. Vet. Res. Commun. 27:101-110. 2003.
35. Nolan, L. K., R. E. Wooley, and R. K. Cooper. Transposon mutagenesis used to study the role of complement resistance in the virulence of an avian Escherichia coli isolate. Avian Dis. 36:398-402. 1992.
36. Peighambari, S. M., D. B. Hunter, P. E. Shewen, and C. L. Gyles. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers. Avian Dis. 46:287-297. 2002.
37. Pfaff-McDonough, S. J., S. M. Horne, C. W. Giddings, J. O. Ebert, C. Doetkott, M. H. Smith, and L. K. Nolan. Complement resistance-related traits among Escherichia coli isolates from apparently healthy birds and birds with colibacillosis. Avian Dis. 44:23-33. 2000.
38. Provence, D. L., and R. Curtiss III. Role of crl in avian pathogenic Escherichia coli: a knockout mutation of crl does not affect hemagglutina-tion activity, fibronectin binding, or curli production. Infect. Immun. 60:4460-4467. 1992.
39. Rodriguez-Siek, K. E., C. W. Giddings, C. Doetkott, T. J. Johnson, M. K. Fakhr, and L. K. Nolan. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 151(Pt 6):2097-2110. 2005.
40. Rodriguez-Siek, K. E., C. W. Giddings, C. Doetkott, T. J. Johnson, and L. K. Nolan. Characterizing the APEC pathotype. Vet. Res. 36:241-256. 2005.
41. Roland, K., K. Karaca, and D. Sizemore. Expression of Escherichia coli antigens in Salmonella Typhimurium as a vaccine to prevent airsacculitis in chickens. Avian Dis. 48:595-605. 2004.
42. Skyberg, J. A., T. J. Johnson, J. R. Johnson, C. Clabots, C. M. Logue, and L. K. Nolan. Acquisition of avian pathogenic escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chick embryos, grow in human urine, and colonize the murine kidney. Infect. Immun. 74(11): 6287-6292. 2006.
43. Sojka, W. J., and R. B. A. Carnaghan. Escherichia coli infections in poultry. Res. Vet. Sci. 2:340-352. 1961.
44. Tivendale, K. A., C. M. Logue, S. Kariyawasam, D. Jordan, A. Hussein, G. Li, Y. Wannemuehler, and L. K. Nolan. Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect. Immun. 78:3412-3419. 2010.
45. Trampel, D. W., and R. W. Griffth. Efficacy of aluminum hydroxide-adjuvanted Escherichia coli bacterin in turkey poults. Avian Dis. 41:263-268. 1997.
46. Vandemaele, F., N. Bleyen, O. Abuaboud, E. van der Meer, A. Jacobs, and B. M. Goddeeris. Immunization with the biologically active lectin domain of PapGII induces strong adhesion-inhibiting antibody responses but not protection against avian pathogenic Escherichia coli. Avian Pathol. 35:238-249. 2006.
47. Vandemaele, F., C. Ververke, N. Bleyen, J. Geys, C. D'Hulst, T. Addwebi, P. van Empel, and B. M. Goddeeris. Immunization with the binding domain of FimH, the adhesin of type 1 fimbriae, does not protect chickens against avian pathogenic Escherichia coli. Avian Pathol. 34: 264-272. 2005.
48. Vidotto, M. C., E. E. Muller, J. C. de Freitas, A. A. Alfieri, I. G. Guimaraes, and D. S. Santos. Virulence factors of avian Escherichia coli. Avian Dis. 34:531-538. 1990.